1 not yet recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Not yet recruiting 1 |
Follow Small-for-Size Syndrome: new trials by email Literature Review of Small-for-Size Syndrome trials Research Report on Small-for-Size Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Octreotide vs. Splenic Artery Ligation for Portal Flow Modulation in Living Donor Liver Transplants (SCALOP Trial) Octreotide (drug), Splenic Artery Ligation (SAL) - Small-for-Size Syndrome | Phase 4 | Not yet recruiting | King Faisal Specialist Hospital & Research Center | 80 | 2025-06-01 | 2025-05-15 |
Octreotide (1) · Pharmaceutical Preparations (1)
King Faisal Specialist Hospital & Research Center (1)
Saudi Arabia (1)
Dieter C. Broering, MD, PhD (1) · Dimitri A. Raptis, MD, MSc, PhD (1) · Massimo Malago, MD, PhD (1)